Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sempra
SRE
|
+$808M |
| 2 |
Southern Company
SO
|
+$780M |
| 3 |
Dominion Energy
D
|
+$546M |
| 4 |
Procter & Gamble
PG
|
+$360M |
| 5 |
Mattel
MAT
|
+$354M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$652M |
| 2 |
Target
TGT
|
+$630M |
| 3 |
Microsoft
MSFT
|
+$586M |
| 4 |
XL
XL Group Ltd.
XL
|
+$560M |
| 5 |
Coca-Cola
KO
|
+$555M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.46% |
| 2 | Financials | 15.6% |
| 3 | Technology | 14.77% |
| 4 | Industrials | 9.28% |
| 5 | Communication Services | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Aurinia Pharmaceuticals
AUPH
$1.97B
| $8.64M | ﹤0.01% |
1,664,400
| – | – |
|
|
AGRX
902
DELISTED
Agile Therapeutics
AGRX
| $8.62M | ﹤0.01% |
1,678
+244
| +17% | +$1.61M |
|
903
RLI Corp
RLI
$5.68B
| $8.57M | ﹤0.01% |
270,436
-465,600
| -63% | -$14.4M |
|
|
USAP
904
DELISTED
Universal Stainless & Alloy
USAP
| $8.5M | ﹤0.01% |
309,200
-21,800
| -7% | -$551K |
|
905
Ameresco
AMRC
$1.15B
| $8.45M | ﹤0.01% |
649,900
| – | – |
|
|
WRI
906
DELISTED
Weingarten Realty Investors
WRI
| $8.39M | ﹤0.01% |
298,974
-70,561
| -19% | -$2.03M |
|
907
iShares Russell 2000 Growth ETF
IWO
$14.5B
| $8.3M | ﹤0.01% |
43,580
-18,616
| -30% | -$3.57M |
|
908
FTI Consulting
FCN
$4.82B
| $8.25M | ﹤0.01% |
170,400
+93,300
| +121% | +$4.21M |
|
|
GGP
909
DELISTED
GGP Inc.
GGP
| $8.21M | ﹤0.01% |
401,062
-219,662
| -35% | -$4.86M |
|
|
PLG
910
Platinum Group Metals
PLG
$164M
| $8.16M | ﹤0.01% |
2,787,849
| – | – |
|
|
DERM
911
DELISTED
Dermira, Inc.
DERM
| $8.1M | ﹤0.01% |
1,013,100
+120,600
| +14% | +$2.63M |
|
|
ERF
912
DELISTED
Enerplus Corporation
ERF
| $8.05M | ﹤0.01% |
+716,800
| New | +$7.8M |
|
|
FMI
913
DELISTED
Foundation Medicine, Inc.
FMI
| $8.03M | ﹤0.01% |
+102,000
| New | +$7.53M |
|
|
NGD
914
DELISTED
New Gold Inc
NGD
| $8.02M | ﹤0.01% |
3,110,000
| – | – |
|
915
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
| $8.02M | ﹤0.01% |
161,350
+15,727
| +11% | +$800K |
|
|
NPKI
916
NPK International
NPKI
$1.21B
| $7.99M | ﹤0.01% |
986,433
-157,900
| -14% | -$1.38M |
|
917
Healthcare Services Group
HCSG
$1.56B
| $7.85M | ﹤0.01% |
180,526
-1,662
| -0.9% | -$81.3K |
|
|
IRDMB
918
DELISTED
Iridium Communications Inc - 6.75% Series B
IRDMB
| $7.73M | ﹤0.01% |
20,000
| – | – |
|
919
Minerva Neurosciences
NERV
$188M
| $7.72M | ﹤0.01% |
154,375
| – | – |
|
920
Bar Harbor Bankshares
BHB
$654M
| $7.68M | ﹤0.01% |
277,000
| – | – |
|
|
FOMX
921
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $7.67M | ﹤0.01% |
1,495,545
+900
| +0.1% | +$5.42K |
|
922
First Internet Bancorp
INBK
$231M
| $7.65M | ﹤0.01% |
206,800
| – | – |
|
|
GOLD
923
DELISTED
Randgold Resources Ltd
GOLD
| $7.61M | ﹤0.01% |
91,423
-29,000
| -24% | -$2.61M |
|
924
Zimmer Biomet
ZBH
$17.7B
| $7.6M | ﹤0.01% |
71,827
-105,379
| -59% | -$12.2M |
|
925
Tetra Tech
TTEK
$8.23B
| $7.59M | ﹤0.01% |
775,000
| – | – |
|
Similar funds
Franklin Resources's Q1 2018 Portfolio in Review
As of Q1 2018, Franklin Resources held 1,595 positions worth $197B, down 5.3% from $208B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Franklin Resources withdrew a net $8.63B in Q1 2018, closing 98 positions and reducing 728 holdings. Its most notable exit was Allergan plc, an estimated $186M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Financials and Technology.
Against the trend, Franklin Resources opened a new position in Nutrien worth $128M.
- Franklin Resources's largest Q1 2018 buy was Nutrien: 2,712,468 shares worth $128M.
- Franklin Resources added most to Sempra in Q1 2018, an estimated $808M increase.
- Franklin Resources's biggest Q1 2018 reduction was Union Pacific, cutting an estimated $652M.
- Franklin Resources fully exited Allergan plc in Q1 2018, selling an estimated $186M.
- Franklin Resources's ten largest holdings make up 14% of its $197B portfolio in Q1 2018.
- Franklin Resources opened 91 new positions and closed 98 in Q1 2018.
- Franklin Resources's portfolio value fell 5.3% quarter-over-quarter to $197B.
Based on Franklin Resources's 13F filing for Q1 2018, filed 10 May 2018.